The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127086711 12708671 1 I 20151001 20160809 20160901 20160901 EXP US-VALIDUS PHARMACEUTICALS LLC-US-2016VAL002489 VALIDUS 0.00 Y 0.00000 20160901 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127086711 12708671 1 PS FUROSEMIDE. FUROSEMIDE 1 Oral 20 MG, TOTAL DAILY DOSE 880 MG Y 16273 20 MG
127086711 12708671 2 SS TREPROSTINIL TREPROSTINIL 1 Oral 2.75 MG, TID 0 2.75 MG TABLET
127086711 12708671 3 SS TREPROSTINIL TREPROSTINIL 1 Oral UNK 0 TABLET
127086711 12708671 4 C PROGRAF TACROLIMUSTACROLIMUS ANHYDROUS 1 4 MG, QD Y 0 4 MG
127086711 12708671 5 C MYFORTIC MYCOPHENOLATE SODIUM 1 Oral 1440 MG, QD U 0 1440 MG
127086711 12708671 6 C VALCYTE VALGANCICLOVIR HYDROCHLORIDE 1 Oral 225 MG, QD U 0 225 MG
127086711 12708671 7 C BACTRIM DS SULFAMETHOXAZOLETRIMETHOPRIM 1 Oral 800-160 MG TOTAL DAILY DOSE U 0
127086711 12708671 8 C PROTONIX PANTOPRAZOLE SODIUM 1 Oral 40 MG, QD U 0 40 MG
127086711 12708671 9 C MIDODRINE MIDODRINE 1 Oral 20 MG, QD U 0 20 MG
127086711 12708671 10 C FLOMAX TAMSULOSIN HYDROCHLORIDE 1 0.4 MG, QD U 0 .4 MG
127086711 12708671 11 C SIMVASTATIN. SIMVASTATIN 1 Oral 20 MG, QD U 0 20 MG
127086711 12708671 12 C DIGOXIN. DIGOXIN 1 Oral 0.125 MG, QD U 0 .125 MG
127086711 12708671 13 C BOSENTAN. BOSENTAN 1 250 MG, QD U 0 250 MG
127086711 12708671 14 C ALLOPURINOL. ALLOPURINOL 1 Oral 100 MG, QD U 0 100 MG
127086711 12708671 15 C WARFARIN WARFARIN 1 Oral 5 MG, QD U 0 5 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127086711 12708671 1 Pulmonary arterial hypertension
127086711 12708671 2 Pulmonary arterial hypertension
127086711 12708671 4 Renal transplant
127086711 12708671 5 Renal transplant
127086711 12708671 6 Renal transplant
127086711 12708671 7 Renal transplant
127086711 12708671 8 Gastrooesophageal reflux disease
127086711 12708671 9 Renal transplant
127086711 12708671 10 Benign prostatic hyperplasia
127086711 12708671 11 Nephropathy
127086711 12708671 12 Nephropathy
127086711 12708671 13 Pulmonary arterial hypertension
127086711 12708671 14 Nephropathy
127086711 12708671 15 Atrial fibrillation

Outcome of event

Event ID CASEID OUTC COD
127086711 12708671 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
127086711 12708671 Blood creatinine increased
127086711 12708671 Diarrhoea

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127086711 12708671 1 20150819 20151104 0
127086711 12708671 2 20151103 0
127086711 12708671 3 20150914 0
127086711 12708671 4 20150620 0
127086711 12708671 5 20150620 0
127086711 12708671 6 20150620 0
127086711 12708671 7 20150620 0
127086711 12708671 8 20150620 0
127086711 12708671 9 20150620 0
127086711 12708671 10 20150620 0
127086711 12708671 11 20130715 0
127086711 12708671 12 20121030 0
127086711 12708671 13 20120726 0